Bioform Medical (NASDAQ:BFRM)

CAPS Rating: 2 out of 5

Recs

0
Player Avatar MD4Beauty (< 20) Submitted: 11/13/2007 5:01:19 PM : Outperform Start Price: $8.40 BFRM Score: -27.99

Bioform markets a dermal filler, Radiesse, which has potential to take market share from Restylane by Medicis. New techniques have been developed which make the injections less painful and easier to perform. The company has priced the product well to compete with other fillers and will be supplying new, thinner (read: less painful) needles with the product in the near future, pending FDA approval.

Featured Broker Partners


Advertisement